Clinical trials in Garmisch-Partenkirchen

Innovative research focusing on Fibrodysplasia Ossificans Progressiva (FOP), evaluating new therapeutic approaches to manage abnormal bone formation. The trials aim to assess safety and effectiveness of novel treatments for this rare genetic condition.

• Bone formation disorders
• Genetic conditions
• Progressive disorders

Studies are investigating targeted therapies to potentially halt disease progression.

Long-term research into eosinophilic esophagitis, examining innovative treatments for this chronic allergic inflammatory condition. The trials focus on evaluating extended safety profiles of new therapeutic agents.

• Inflammatory conditions
• Esophageal disorders
• Chronic diseases

Research aims to improve long-term management options for patients.

Advanced studies in breast cancer and chronic lymphocytic leukemia, particularly focusing on hormone receptor-positive HER2-negative cases and high-risk CLL variants. Trials evaluate combination therapies and targeted treatments.

• Metastatic breast cancer
• Leukemia treatments
• Targeted therapies

Research emphasizes personalized treatment approaches for specific cancer subtypes.